Synergy Pharmaceuticals, Inc.
(NASDAQ : SGYP)

( )
SGYP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
0.14%172.980.4%$140.88m
JAZZJazz Pharmaceuticals Plc
0.60%177.112.2%$122.81m
SAGESAGE Therapeutics, Inc.
0.36%168.629.6%$112.98m
PRGOPerrigo Co. Plc
-0.77%75.836.7%$91.67m
ENDPEndo International Plc
0.09%11.228.9%$74.39m
MNKMallinckrodt Plc
0.34%21.9021.1%$72.27m
ZGNXZogenix, Inc.
-0.42%58.9511.9%$67.46m
ICPTIntercept Pharmaceuticals, Inc.
0.05%95.7321.8%$67.42m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.18%148.616.8%$63.63m
CTLTCatalent Inc
0.39%43.352.6%$61.15m
MDCOMedicines Company
0.81%40.0821.8%$40.02m
SUPNSupernus Pharmaceuticals, Inc.
-0.82%54.256.3%$39.86m
UTHRUnited Therapeutics Corporation
0.78%124.0914.4%$37.15m
PTLAPortola Pharmaceuticals, Inc.
-0.45%39.927.7%$34.99m
AERIAerie Pharmaceuticals, Inc.
0.41%73.907.9%$30.84m

Company Profile

Synergy Pharmaceuticals, Inc. engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai on November 15, 2005 and is headquartered in New York, NY.